Dataset Information

Adaptive cardiac resynchronization therapy for dilated cardiomyopathy with functional mitral regurgitation.

ABSTRACT: We report the case of a man in his 60s who had dilated cardiomyopathy with severe functional mitral regurgitation. Four years after a cardiac resynchronization therapy (CRT) device with an implantable cardioverter defibrillator was implanted, this device was replaced with an adaptive CRT device because of battery consumption. Seven months after replacement of this device, the left ventricular pacing to right ventricular activation and the atrioventricular delay from automatic adjustments contributed to less functional mitral regurgitation. The findings from our case suggest that optimal CRT, by measuring intracardiac conduction parameters, is effective for functional mitral regurgitation.

SUBMITTER: Nagata Y

PROVIDER: S-EPMC5634678 | biostudies-other | 2017 Oct

REPOSITORIES: biostudies-other

ACCESS DATA

Publications

Adaptive cardiac resynchronization therapy for dilated cardiomyopathy with functional mitral regurgitation.

Nagata Yoshiki Y Nakagawa Yoichiro Y Takeda Yusuke Y Emoto Kenji K Kinoshita Masaki M Chikata Akio A Maruyama Michiro M Usuda Kazuo K

Journal of arrhythmia 20170429 5

We report the case of a man in his 60s who had dilated cardiomyopathy with severe functional mitral regurgitation. Four years after a cardiac resynchronization therapy (CRT) device with an implantable cardioverter defibrillator was implanted, this device was replaced with an adaptive CRT device because of battery consumption. Seven months after replacement of this device, the left ventricular pacing to right ventricular activation and the atrioventricular delay from automatic adjustments contrib ...[more]

PMID: 29021862

Similar Datasets

Project description:BackgroundAppropriate surgical management of moderate functional mitral regurgitation (MR) at the time of coronary artery bypass graft (CABG) surgery remains controversial. A recent study demonstrated no survival benefit from adding mitral repair to CABG for patients with moderate functional MR. Preoperative prediction of reverse remodelling is crucial in making the decision to add mitral valve repair to CABG. Late gadolinium-enhanced magnetic resonance imaging (LGE MRI) offers a reference method to assess myocardial viability.Case summaryA 60-year-old man with ischaemic cardiomyopathy was admitted to our hospital with exacerbation of heart failure symptoms. Left ventricular (LV) dilatation, severe impairment of LV systolic function, and moderate MR due to tethering were noted on transthoracic echocardiography. The mitral regurgitant jet was central. Intravenous administration of furosemide and human atrial natriuretic peptide was initiated. The patient experienced an episode of ventricular tachycardia, and coronary angiography demonstrated triple-vessel disease. On LGE MRI, subendocardial infarction with a transmural extent of 25-50% was revealed in the inferior, posterior, and lateral walls. Findings from LGE MRI suggested that myocardial viability had been preserved. After performing CABG and cardiac resynchronization therapy, LV volume was substantially decreased and moderate MR was significantly improved without surgical mitral repair. On speckle tracking echocardiography before surgery, a significant difference in the times to peak radial strain between the lateral wall (462 ms) and inferior wall (17 ms) indicated the presence of LV dyssynchrony. Left ventricular dyssynchrony was substantially improved after CABG and cardiac resynchronization therapy defibrillator implantation.DiscussionIn patients with ischaemic cardiomyopathy and moderate functional MR, acquisition of LGE MRI of the LV should be considered to evaluate the viability of LV myocardium. Findings from LGE MRI of the LV can potentially influence the surgical strategy. In patients with preserved viability of LV myocardium, functional MR could be improved after CABG without any surgical repair.

Project description:Objectives: To test whether (1) electromechanical dyssynchrony induces region-specific alterations in the myocardial transcriptome and (2) dyssynchrony-induced gene expression changes can be corrected by cardiac resynchronization (CRT). Background: To date, CRT is the only heart failure treatment that can both acutely and chronically increase systolic function and prolong survival, something not yet achieved by a drug therapy. However, the mechanisms underlying the benefits of CRT remain elusive. Methods: Adult dogs underwent left bundle branch ablation (LBBB) and right atrial pacing at 200 bpm for either 6 weeks (dyssynchronous heart failure, DHF, n=12) or 3 weeks followed by 3 weeks of resynchronization by bi-ventricular pacing at the same pacing rate (CRT, n=10). Control animals without LBBB were not paced (NF, n=14). Echocardiography and invasive hemodynamic measurements were performed at 3 and 6 weeks. At 6 weeks, RNA was isolated from the anterior and lateral LV walls and hybridized onto canine-specific 44K microarrays. Results: In DHF, transcriptional changes consistent with re-expression of a fetal gene program were primarily observed in the anterior LV, resulting in increased regional heterogeneity of gene expression within the left ventricle. Dyssynchrony-induced region-specific expression changes in 1050 transcripts were reversed by CRT to levels of NF hearts (false discovery rate <5%). CRT remodeled transcripts with metabolic and cell signaling function and greatly reduced regional heterogeneity of gene expression compared with DHF. Conclusions: Our results demonstrate a profound effect of electromechanical dyssynchrony on the regional cardiac transcriptome, causing gene expression changes primarily in the anterior LV wall. CRT corrected the alterations in gene expression in the anterior wall by reversing the fetal gene expression pattern, supporting a global effect of biventricular pacing on the ventricular transcriptome that extends beyond the pacing site in the lateral wall.

Dataset Information

Adaptive cardiac resynchronization therapy for dilated cardiomyopathy with functional mitral regurgitation.

Publications

Adaptive cardiac resynchronization therapy for dilated cardiomyopathy with functional mitral regurgitation.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure